2015		2016		2017		Rate(Cases per 100,000 per month)		Monthly Rate Comparison
Disease	May No.	YTD No.	May No.	YTD No.	May No.	YTD No.	May (2012-2016 aggregated)	May (2017)	Significant change bet. current & past 5-year?~~
VACCINE PREVENTABLE
DIPHTHERIA	0	0	0	0	0	0	0.00	0.00
HAEMOPHILUS INFLUENZA (INVASIVE)	.	11	.	11	0	13	0.10	0.00	X
HEPATITIS A	.	.	.	6	0	0	0.08	0.00	X
HEPATITIS B (ACUTE)	.	.	.	7	.	8	0.09	0.14
INFLUENZA	16	440	13	556	62	571	1.26	2.85	X
MEASLES	0	9	0	0	0	0	0.00	0.00
MUMPS	0	0	0	0	0	.	0.00	0.00
PERTUSSIS	18	59	.	19	.	26	0.50	0.09	X
POLIOMYELITIS	0	0	0	0	0	0	0.00	0.00
RUBELLA	0	0	0	0	0	0	0.00	0.00
TETANUS	0	0	0	0	0	0	0.00	0.00
SEXUALLY TRANSMITTED
CHLAMYDIA	740	4119	894	4411	1069	4890	40.77	49.08	X
GONORRHEA	223	1143	272	1285	381	1669	10.24	17.49	X
SYPHILIS (EARLY LATENT)	31	151	44	228	42	178	1.30	1.93
SYPHILIS (PRIMARY & SECONDARY)	22	95	20	130	35	192	0.76	1.61	X
ENTERICS
AMEBIASIS	0	.	0	.	.	.	0.01	0.05
BOTULISM-INTESTINAL (INFANT)	0	0	0	0	0	0	0.00	0.00
CAMPYLOBACTERIOSIS	11	37	8	44	10	45	0.40	0.46
CHOLERA	0	0	0	0	0	0	0.00	0.00
CRYPTOSPORIDIOSIS	0	.	0	0	.	.	0.02	0.05
GIARDIA	.	15	.	19	.	11	0.20	0.05
ROTAVIRUS	9	61	11	15	8	44	0.52	0.37
SALMONELLOSIS	11	48	13	53	9	53	0.71	0.41
SHIGA-TOXIN PRODUCING E. COLI	0	9	.	18	0	7	0.11	0.00	X
SHIGELLOSIS	.	8	.	18	.	16	0.08	0.18
TYPHOID FEVER	0	.	0	.	0	0	0.01	0.00
VIBRIO (NON-CHOLERA)	0	0	0	0	0	0	0.01	0.00
YERSINIOSIS	0	0	0	0	0	.	0.00	0.00
OTHER
ANTHRAX	0	0	0	0	0	0	0.00	0.00
BOTULISM INTOXICATION	0	0	0	0	0	0	0.00	0.00
BRUCELLOSIS	0	0	0	.	0	0	0.00	0.00
COCCIDIOIDOMYCOSIS	6	29	8	33	8	47	0.27	0.37
DENGUE FEVER	0	0	0	0	0	0	0.00	0.00
ENCEPHALITIS	0	.	0	0	0	.	0.00	0.00
HANTAVIRUS	0	0	0	0	0	0	0.00	0.00
HEMOLYTIC UREMIC SYNDROME (HUS)	0	0	0	0	0	0	0.00	0.00
HEPATITIS C (ACUTE)	0	5	.	11	.	9	0.02	0.05
HEPATITIS D	0	0	0	0	0	0	0.00	0.00
INVASIVE GROUP A STREP.	0	0	0	0	0	0	0.00	0.00
LEGIONELLOSIS	.	10	.	6	.	9	0.09	0.18
LEPROSY (HANSEN’S DISEASE)	0	0	0	0	0	0	0.01	0.00
LEPTOSPIROSIS	0	0	0	0	0	0	0.00	0.00
LISTERIOSIS	0	.	0	0	0	0	0.00	0.00
LYME DISEASE	0	.	.	.	0	5	0.04	0.00
MALARIA	0	0	.	.	0	0	0.03	0.00
MENINGITIS, ASEPTIC/VIRAL	6	15	0	.	.	8	0.13	0.09
MENINGITIS, BACTERIAL	5	12	.	19	.	9	0.10	0.14
MENINGOCOCCAL DISEASE	0	0	0	.	0	.	0.00	0.00
PLAGUE	0	0	0	0	0	0	0.00	0.00
PSITTACOSIS	0	0	0	.	0	0	0.00	0.00
Q FEVER	0	.	0	0	0	0	0.00	0.00
RABIES (HUMAN)	0	0	0	0	0	0	0.00	0.00
RELAPSING FEVER	0	0	0	0	0	0	0.00	0.00
ROCKY MOUNTAIN SPOTTED FEVER	0	0	.	.	0	0	0.02	0.00
RSV (RESPIRATORY SYNCYTIAL VIRUS)	5	1092	12	661	13	854	0.82	0.60
STREPTOCOCCUS PNEUMONIAE, IPD	8	62	10	83	18	110	0.29	0.83	X
TOXIC SHOCK SYN	0	0	0	0	0	0	0.00	0.00
TOXIC SHOCK SYN (STREPTOCOCCAL)	.	6	.	11	8	16	0.07	0.37	X
TULAREMIA	0	0	0	0	0	0	0.00	0.00
UNUSUAL ILLNESS	0	0	0	0	0	0	0.00	0.00
WEST NILE VIRUS (ENCEPHALITIS)	0	0	0	0	0	.	0.00	0.00
WEST NILE VIRUS (FEVER)	0	0	0	0	0	0	0.00	0.00
ZIKA VIRUS DISEASE, CONGENITAL~	0	0	0	0	0	0	0.00	0.00
ZIKA VIRUS DISEASE, NON-CONGENITAL~	0	0	0	7	0	0	0.00	0.00
ZIKA VIRUS INFECTION, CONGENITAL~	0	0	0	0	0	0	0.00	0.00
ZIKA VIRUS INFECTION, NON-CONGENITAL~	0	0	.	.	0	0	0.00	0.00

*Use of illness onset date in data aggregation for cases other than STD or TB (since Jan-2013) causes changes in cases reported here from previously released reports. Numbers are provisional including confirmed, probable and suspect cases that are reportable to CDC. HIV/AIDS/TB case counts provided on a quarterly basis. Data suppression denoted by ‘.’ applies if number of cases <5. Monthly disease total (excluding STD and TB cases)=158 (reported total=1685). Monthly congenital syphilis cases (suppression applied) for 2015-2017 were 0,.,0(YTD totals of .,.,7) respectively.

~Zika case definitions added in 2016.

~~Confidence intervals (not shown) for the monthly disease incidence rates provided a basis for an informal statistical test to determine if the current monthly rates changed significantly from those of the previous 5 years aggregated. Text in green where rates decreased and in red where rates increased. Statistically significant changes indicated by ‘X’ (rate comparisons made if 5+ cases reported in the current month of this year or previous 5 years aggregated).